| 41.99 Delayed Data As of 4:02pm ET |  +0.32 / +0.77%Today’s Change | 35.32 Today|||52-Week Range 46.47 | -3.80% Year-to-Date |
| Previous close | 41.67 |
| Today’s open | 41.69 |
| Day’s range | 41.55 - 42.21 |
| Volume | 23,979,686 |
| Average volume (3 months) | 24,363,377 |
| Market cap | $230.5B |
| Earnings growth (last year) | -46.78% |
| Earnings growth (this year) | -3.70% |
| Earnings growth (next 5 years) | +3.74% |
| Revenue growth (last year) | +2.10% |
| P/E ratio | 21.5 |
| Price/Sales | 4.86 |
| Price/Book | 3.74 |
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | +1.48 | +1.86% |
| NVSNovartis | +1.52 | +1.84% |
| ABTAbbott Laboratories | +0.23 | +0.30% |
| ABBVAbbVie | +0.71 | +0.88% |
| Next reporting date | July 30, 2019 |
| EPS forecast (this quarter) | $0.74 |
| Annual revenue (last year) | $53.6B |
| Annual profit (last year) | $11.2B |
| Net profit margin | 20.77% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Director, Chief Executive & Operating Officer Albert Bourla |
Chief Financial Officer & EVP-Business Operations Frank A. D'Amelio |
Corporate headquarters New York, New York |
